EU regulator backs J&J vaccine, despite risk
3 years ago
13.2K
Europe's drug regulator has found a possible link between Johnson & Johnson's COVID-19 vaccine and rare blood clotting issues in adults who received doses in the United States, but backed its overall benefits against any risks. Olivia Chan reports.
Loading comments...
-
0:43
Reuters
2 hours agoArgentinians march against Milei's education cuts
258 -
2:59
Reuters
3 years agoBiden says vaccine plan on track despite J&J pause
3043 -
1:48
WFTS
3 years agoCDC delays J&J vaccine recommendations
1633 -
1:34
Reuters
3 years agoJ&J files for U.S. COVID-19 vaccine authorization
415 -
2:08
Reuters
3 years agoJ&J COVID-19 vaccine 66% effective globally
6046 -
1:58
Reuters
3 years agoJ&J pause shouldn't prompt vaccine hesitancy: Fauci
5549 -
1:37
Reuters
3 years agoU.S. could roll out J&J vaccine next week
1382 -
0:52
Newsy
3 years agoGlobal COVID Cases Grow Despite Vaccine Efforts
2896 -
1:52
KGTV
3 years agoDowntown Vaccine Super Station remains open despite rain
222 -
2:23
Reuters
3 years agoJ&J partner disposed of spoilt COVID vaccine batch
3511
